Mark Davies Succeeds Harry as Primary Health Properties CEO

Primary Health Properties has announced the appointment of Mark Davies, ACA, as its new Chief Executive Officer, effective from the conclusion of its annual meeting on 24 April. He will be taking over from Harry Hyman, the founder of PHP, whose departure was announced in December of the previous year.

Primary Health Properties, a company that specializes in investing in modern primary healthcare facilities, described Davies as a highly experienced FTSE 250 executive, and Steve Owen, Chairman of Primary Health Properties, expressed his satisfaction with Mark Davies’ appointment.

Mark has previously held CEO and CFO roles in both listed companies and private equity firms. Notably, he co-founded NewRiver REIT in 2009 and played a crucial role in guiding the group from its initial public offering (IPO) to inclusion in the FTSE 250 within seven years. Davies also served as CFO of NewRiver for over 12 years and concurrently held the positions of CEO and executive chairman of Hawthorn for five years. Currently, he serves as the senior independent director at Palace Capital, a London-listed REIT.

Have you read?
Richest countries in the world by GDP per capita in 2023.
Countries With The Highest And Lowest Average Salaries, 2023.
Best Fashion Schools In The World.
Best Business Schools In The World.
The World’s Best CEOs And C-Suite Executives, 2023.

This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.

Email Address*

Name